- Home
- ONC
as 08-01-2025 4:00pm EST
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
Upcoming Earnings Alert:
Get ready for potential market movements as BeiGene Ltd. American Depositary Shares ONC prepares to release earnings report on 06 Aug 2025.
| Founded: | 2010 | Country: | Switzerland |
| Employees: | N/A | City: | GRAND CAYMAN |
| Market Cap: | 31.5B | IPO Year: | N/A |
| Target Price: | $332.44 | AVG Volume (30 days): | 411.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $155.75 - $308.87 | Next Earning Date: | 08-06-2025 |
| Revenue: | $4,175,868,000 | Revenue Growth: | 51.16% |
| Revenue Growth (this year): | 865.19% | Revenue Growth (next year): | 21.12% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day
Business Wire
a month ago
BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®
Simply Wall St.
a month ago
Exploring US High Growth Tech Stocks To Watch In June 2025
Business Wire
2 months ago
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025
Business Wire
2 months ago
U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications
Business Wire
2 months ago
BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025
Simply Wall St.
2 months ago
BeOne Medicines And 2 Stocks That May Be Undervalued By The Market
Investor's Business Daily
2 months ago
Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.